Literature DB >> 23105595

Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease.

Joya Ghosh1, T K Mishra, Y N Rao, S K Aggarwal.   

Abstract

Coronary artery disease is a major cause of morbidity and has various risk factors. Lipid profile i.e. low HDL-cholesterol, high LDL cholesterol, high total cholesterol, high triglycerides playing important role in its causation. Recently interest has been shown in the oxidized fraction of LDL as one of the risk factors. In the present study 60 age and sex matched normal healthy individuals were taken as controls and 60 patients of CAD were taken. Cholesterol was measured by enzymatic method, HDL cholesterol by phosphotungstate precipitation method. Serum levels of LDL fraction of cholesterol was measured by a new and simpler method of precipitation. Result was expressed as mol/L of diene conjugates. It was observed that LDL cholesterol, VLDL cholesterol, total cholesterol, total cholesterol: HDL cholesterol, LDL cholesterol: HDL cholesterol were significantly raised and HDL cholesterol was significantly low in patients. (p<0.001). Though HDL cholesterol was significantly raised in females as compared to males in both the groups (p<0.001). Serum level of total cholesterol, oxidized LDL:HDL cholesterol were also raised significantly (p<0.05). The level of oxidized LDL showed an increasing trend in patients.

Entities:  

Keywords:  LDL; Oxidised; coronary artery disease; lipoprotein

Year:  2006        PMID: 23105595      PMCID: PMC3453751          DOI: 10.1007/BF02913092

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  19 in total

1.  Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.

Authors:  S Toshima; A Hasegawa; M Kurabayashi; H Itabe; T Takano; J Sugano; K Shimamura; J Kimura; I Michishita; T Suzuki; R Nagai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

Review 2.  [Oxidized LDL in patients with coronary heart disease and normal subjects].

Authors:  A Hasegawa; S Toshima; A Nakano; R Nagai
Journal:  Nihon Rinsho       Date:  1999-12

Review 3.  Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis.

Authors:  D Steinberg
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

4.  Dietary and pharmacologic therapy for the lipid risk factors.

Authors: 
Journal:  JAMA       Date:  1983-10-14       Impact factor: 56.272

5.  Evaluation of HDL2 and HDL3 cholesterol by a precipitation procedure in a normal population and in different hyperlipidemic phenotypes.

Authors:  S Martini; G Baggio; L Baroni; G B Enzi; R Fellin; M R Baiocchi; G Crepaldi
Journal:  Clin Chim Acta       Date:  1984-03-13       Impact factor: 3.786

Review 6.  How LDL receptors influence cholesterol and atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Sci Am       Date:  1984-11       Impact factor: 2.142

7.  Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein.

Authors:  T Ohta; K Takata; S Horiuchi; Y Morino; I Matsuda
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

8.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors:  V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

Review 9.  Plasma triglyceride and coronary heart disease.

Authors:  M A Austin
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

10.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

View more
  4 in total

1.  Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review.

Authors:  Paramjit K Sandhu; Salma M A Musaad; Alan T Remaley; Stephanie S Buehler; Sonya Strider; James H Derzon; Hubert W Vesper; Anne Ranne; Colleen S Shaw; Robert H Christenson
Journal:  J Appl Lab Med       Date:  2016-08-01

2.  Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study.

Authors:  Sabitha Palazhy; Prakash Kamath; Damodaran M Vasudevan
Journal:  Indian Heart J       Date:  2015-04-27

3.  Biochemical and genetic studies on cardiometabolic syndrome.

Authors:  A Supriya Simon; D Dinesh Roy; V Jayapal; T Vijayakumar
Journal:  Indian J Clin Biochem       Date:  2010-05-27

4.  Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk.

Authors:  Katarzyna Bergmann
Journal:  EJIFCC       Date:  2010-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.